A recent investigation led by the ESPOIR investigators derived and independently validated a risk score for subclinical RA-ILD, which included male sex, older age, RA disease activity, and the MUC5B promoter variant, a known genetic risk factor for RA-ILD[26,27]. The gene discussed is MUC5B; the disease is rheumatoid arthritis.